Federal award (DELIVERY ORDER, fiscal year 2024)
Recipient: DMS PHARMACEUTICAL GROUP INC
Awarding agency: Department of Defense / Defense Logistics Agency
Funding agency: Department of Defense / Defense Logistics Agency
Period of performance: 2024-12-09 to 2024-12-10
Current total value of award: $2625.96
Description: 4566684375!HEPLISAV-B 20 MCG/0.5 ML SYRNG 0.5ML